Search Results for: metastases
Melanoma Brain Metastases: An Update on the Use of Immune Checkpoint Inhibitors and Molecularly Targeted Agents.
Melanoma Literature
Publication date: May 09, 2022 Brain metastases from melanoma are no longer uniformly associated with dismal outcomes. Impressive tumor tissue-based (craniotomy) translational research has consistently shown that distinct patient subgroups ... Read more
PRAME Immunocytochemistry for the Diagnosis of Melanoma Metastases in Cytological Samples.
Melanoma Literature
Publication date: Mar 06, 2022 (1) Background: Fine-needle aspiration cytology is often used for the pre-operative diagnosis of melanoma metastases. The diagnosis may not be confidently established based on morphology ... Read more
Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-100M for the Treatment of Melanoma Brain Metastases
Melanoma News
Publication date: Apr 22, 2022 This phase I trial finds out the side effects and possible benefits of stereotactic radiosurgery and immune checkpoint inhibitors with NovoTTF-100M for the treating of ... Read more
Radiation Dose Aspects of Hepatic Artery Infusion Chemotherapy in Uveal Melanoma Patients with Liver Metastases.
Melanoma Literature
Publication date: Apr 18, 2022 In uveal melanoma patients, liver metastases can be treated by hepatic artery infusion chemotherapy (HAIC). During this procedure, melphalan or, less frequently, fotemustine is infused ... Read more
Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism.
Melanoma Literature
Publication date: Apr 11, 2022 Whole-brain radiotherapy (WBRT) is the treatment backbone for many patients with brain metastasis; however, its efficacy in preventing disease progression and the associated toxicity have ... Read more
From Postoperative to Preoperative: A Case Series of Hypofractionated and Single-Fraction Neoadjuvant Stereotactic Radiosurgery for Brain Metastases.
Melanoma Literature
Publication date: Apr 01, 2022 Postoperative stereotactic radiosurgery after resection of brain metastases is currently the standard of care. However, rates of leptomeningeal disease (LMD) after postoperative stereotactic radiosurgery have ... Read more
Stereotactic radiosurgery for melanoma brain metastases: Concurrent immune checkpoint inhibitor therapy associated with superior clinicoradiological response outcomes.
Melanoma Literature
Publication date: Mar 27, 2022 This study assessed long-term clinical and radiological outcomes following treatment with combination stereotactic radiosurgery (SRS) and immunotherapy (IT) for melanoma brain metastases (BM). A retrospective ... Read more
Stereotactic radiosurgery for melanoma brain metastases: Concurrent immune checkpoint inhibitor therapy associated with superior clinicoradiological response outcomes.
Melanoma Literature
Publication date: Mar 27, 2022 This study assessed long-term clinical and radiological outcomes following treatment with combination stereotactic radiosurgery (SRS) and immunotherapy (IT) for melanoma brain metastases (BM). A retrospective ... Read more
Evolution of bone metastases in patients receiving at least three months of checkpoint inhibitors.
Melanoma Literature
Publication date: Mar 19, 2022 To investigate the evolution of bone metastases in patients receiving immune checkpoint inhibitors (ICI). A single-center retrospective study included cancer patients with bone metastases treated ... Read more